Get the app!
Back to Trades
Total Value
$1.1M
Net $1.1M sold
Filing Date
Oct 16, 2026
8 transactions
Sales
$1.1M
8 transactions

Trade Summary

On Oct 14, 2026 through Oct 15, 2026, Atay Oguzhan, Chairman and CEO, Director, sold $1.1M of BillionToOne, Inc. (BLLN) across 8 transactions. The filing covers Class A Common Stock and reflects net selling of $1.1M. Reported prices ranged from $2.80 to $102.78. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Company Information

Company Name
BillionToOne, Inc.
Ticker Symbol
BLLN
CIK
0002070849

Insider Information

Role
Chairman and CEO, Director
Location
MENLO PARK, CA

Filing Details

Filing Date
Oct 16, 2026
Transaction Date
Oct 14, 2026
Accession Number
0002088549-26-000015
Form Type
4
Net Trading Amount
-$1.1M

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Oct 14, 2026Class A Common Stock3,183$2.80Exercise$8.9K
Oct 14, 2026Class A Common Stock3,083$98.32Sale$303.1K
Oct 14, 2026Class A Common Stock100$99.00Sale$9.9K
Oct 15, 2026Class A Common Stock5,150$2.80Exercise$14.4K
Oct 15, 2026Class A Common Stock900$98.43Sale$88.6K
Oct 15, 2026Class A Common Stock1,861$99.84Sale$185.8K
Oct 15, 2026Class A Common Stock1,276$100.60Sale$128.4K
Oct 15, 2026Class A Common Stock980$101.79Sale$99.8K
Oct 15, 2026Class A Common Stock133$102.78Sale$13.7K
Oct 14, 2026Class A Common Stock2,667$98.00Sale$261.4K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Oct 14, 2026BLLN derivative3,183$2.80Exercise$8.9K
Oct 15, 2026BLLN derivative5,150$2.80Exercise$14.4K

Want live alerts when Atay Oguzhan trades again?

Download Insider Trades to track BLLN, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

Footnotes

  1. (F1)The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026.
  2. (F2)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.000 to $98.990 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. (F3)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.000 to $98.770 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. (F4)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.270 to $100.250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. (F5)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.270 to $101.200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. (F6)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.370 to $102.140 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. (F7)The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.765 to $102.830 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. (F8)The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person's spouse on June 7, 2026.
  9. (F9)Represents shares held by the Reporting Person's spouse.
  10. (F10)The options are fully vested and exercisable.

SEC Filing